256 related articles for article (PubMed ID: 36225939)
21. Classification and clinical significance of immunogenic cell death-related genes in Plasmodium falciparum infection determined by integrated bioinformatics analysis and machine learning.
Zhang YH; Xie LH; Li J; Qi YW; Shi JJ
Malar J; 2024 Feb; 23(1):48. PubMed ID: 38360586
[TBL] [Abstract][Full Text] [Related]
22. EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma Based on an Integrative Analysis.
Dai Z; Liu Z; Yang R; Cao W; Ji T
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830696
[TBL] [Abstract][Full Text] [Related]
23. Single-cell RNA datasets and bulk RNA datasets analysis demonstrated
Tu J; Wang D; Zheng X; Liu B
Front Immunol; 2023; 14():911368. PubMed ID: 36814925
[TBL] [Abstract][Full Text] [Related]
24. Identification of Immunogenic Cell-Death-Related Subtypes and Development of a Prognostic Signature in Gastric Cancer.
Gan X; Tang X; Li Z
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979463
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis-related genes-based prognostic signature for osteosarcoma.
Yang F; Zhang Y
Aging (Albany NY); 2022 May; 14(9):3813-3825. PubMed ID: 35504036
[TBL] [Abstract][Full Text] [Related]
26. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
27. The Prognostic Model Established by the Differential Expression Genes Based on CD8
Chen Y; Yan W; Wang H; Ou Z; Chen H; Huang Z; Yang J; Liu B; Ou F; Zhang H
Mediators Inflamm; 2023; 2023():6563609. PubMed ID: 36816742
[TBL] [Abstract][Full Text] [Related]
28. Integrated analysis of single-cell RNA-seq dataset and bulk RNA-seq dataset constructs a prognostic model for predicting survival in human glioblastoma.
Lai W; Li D; Kuang J; Deng L; Lu Q
Brain Behav; 2022 May; 12(5):e2575. PubMed ID: 35429411
[TBL] [Abstract][Full Text] [Related]
29. Identification and Development of a Novel 4-Gene Immune-Related Signature to Predict Osteosarcoma Prognosis.
Cao M; Zhang J; Xu H; Lin Z; Chang H; Wang Y; Huang X; Chen X; Wang H; Song Y
Front Mol Biosci; 2020; 7():608368. PubMed ID: 33425993
[TBL] [Abstract][Full Text] [Related]
30. Construction of Molecular Subtype and Prognosis Prediction Model of Osteosarcoma Based on Aging-Related Genes.
Dong C; Sun Y; Zhang Y; Qin B; Lei T
J Oncol; 2022; 2022():8177948. PubMed ID: 36157228
[TBL] [Abstract][Full Text] [Related]
31. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
32. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
Wang H; Li J; Li X
Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
[TBL] [Abstract][Full Text] [Related]
33. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
34. SELPLG Expression Was Potentially Correlated With Metastasis and Prognosis of Osteosarcoma.
Wang B; Sun Y
Pathol Oncol Res; 2022; 28():1610047. PubMed ID: 35153625
[No Abstract] [Full Text] [Related]
35. MFNG is an independent prognostic marker for osteosarcoma.
Gao Y; Luo L; Qu Y; Zhou Q
Eur J Med Res; 2023 Jul; 28(1):256. PubMed ID: 37496053
[TBL] [Abstract][Full Text] [Related]
36. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Immune-Stromal Score-Based Gene Signature and Molecular Subtypes in Osteosarcoma: Implications for Prognosis and Tumor Immune Microenvironment.
Zheng D; Yang K; Chen X; Li Y; Chen Y
Front Genet; 2021; 12():699385. PubMed ID: 34630511
[No Abstract] [Full Text] [Related]
38. Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8
Xie T; Feng W; He M; Zhan X; Liao S; He J; Qin Z; Li F; Xu J; Liu Y; Wei Q
Exp Biol Med (Maywood); 2023 Jan; 248(2):130-145. PubMed ID: 36511103
[TBL] [Abstract][Full Text] [Related]
39. Development and Validation of a Novel Prognosis Model Based on a Panel of Three Immunogenic Cell Death-Related Genes for Non-Cirrhotic Hepatocellular Carcinoma.
Gong J; Yu R; Hu X; Luo H; Gao Q; Li Y; Tan G; Luo H; Qin B
J Hepatocell Carcinoma; 2023; 10():1609-1628. PubMed ID: 37781718
[TBL] [Abstract][Full Text] [Related]
40. Necrotizing apoptosis-related genes prognosis and treatment effect analysis of osteosarcoma in children.
Chen Y; Wu L; Li Y; Zheng J; Zhong S; Gu S; Chen J
J Gene Med; 2024 Jan; 26(1):e3646. PubMed ID: 38100138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
